Form4insider filings, from the source

Insider holders · CIK 0001178879

AMICUS THERAPEUTICS, INC. · FOLD

Every insider with a reported Table I holding at this company, ranked by their last-reported share count. A balance is only as fresh as its filing — the report date sits next to every row on purpose. ← Back to activity

InsiderDirect sharesIndirect sharesTotal reportedLast report (ET)From
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD10% Owner—20,724,42420,724,424Feb 19, 2019 · 4:50 pm ESTForm 4
PERCEPTIVE ADVISORS LLC10% Owner—20,724,42420,724,424Feb 19, 2019 · 4:50 pm ESTForm 4
Joseph Edelman10% Owner—20,724,42420,724,424Feb 19, 2019 · 4:50 pm ESTForm 4
Jeremy Green10% Owner—12,956,44612,956,446Jun 13, 2016 · 7:11 pm EDTForm 4
Redmile Group, LLC10% Owner—12,956,44612,956,446Jun 13, 2016 · 7:11 pm EDTForm 4
John F CrowleyChairman & CEO668,08164,895732,976Mar 5, 2019 · 5:47 pm ESTForm 4
Hung DoChief Science Officer438,268—438,268Jan 17, 2019 · 8:48 pm ESTForm 4
Bradley L CampbellChief Operating Officer239,360—239,360Jan 24, 2019 · 5:06 pm ESTForm 4
Ellen RosenbergChief Legal Officer133,54815,000148,548Jan 10, 2019 · 6:10 pm ESTForm 4
Jay BarthChief Medical Officer129,76731129,798Feb 27, 2019 · 5:30 pm ESTForm 4
Daphne QuimiChief Financial Officer117,953—117,953Jan 10, 2019 · 6:12 pm ESTForm 4
William D Baird IIIChief Financial Officer117,622—117,622Oct 17, 2018 · 6:28 pm EDTForm 4
David Michael ClarkChief People Officer108,057—108,057Jan 10, 2019 · 6:18 pm ESTForm 4
Allsop DavidSVP International50,000—50,000Apr 28, 2015 · 5:01 pm EDTForm 4
Kurt J. AndrewsSVP, Human Resources35,469—35,469Jul 5, 2018 · 4:25 pm EDTForm 4
Enrique DiloneSVP, Technical Operations30,688—30,688Jun 23, 2015 · 8:09 pm EDTForm 4
Ken ValenzanoSVP, Pharmacology & Biology27,687—27,687Jul 15, 2015 · 5:05 pm EDTForm 4
Mark BaldryVP Global Marketing25,000—25,000Jun 4, 2015 · 6:56 pm EDTForm 4
Jeff CastelliSVP, Program Management25,000—25,000Jun 24, 2015 · 7:07 pm EDTForm 4
Kenneth PeistVP, Legal & IP18,874—18,874Jan 6, 2016 · 4:18 pm ESTForm 4
Samantha ProutPrincipal Accounting Officer11,919—11,919Jan 10, 2019 · 6:24 pm ESTForm 4
Lynn Dorsey BleilDirector9,600—9,600Sep 11, 2018 · 7:23 pm EDTForm 4
Michael RaabDirector8,895—8,895Jun 11, 2018 · 4:39 pm EDTForm 4
Glenn SblendorioDirector8,895—8,895Jun 11, 2018 · 4:46 pm EDTForm 4
Craig A WheelerDirector8,895—8,895Jun 11, 2018 · 4:41 pm EDTForm 4
Margaret G McGlynnDirector8,895—8,895Jun 11, 2018 · 4:48 pm EDTForm 4
Donald J Hayden Jr.Director8,895—8,895Jun 11, 2018 · 4:44 pm EDTForm 4
Ted W LoveDirector8,895—8,895Jun 11, 2018 · 4:42 pm EDTForm 4
Robert EssnerDirector8,895—8,895Jun 11, 2018 · 4:43 pm EDTForm 4
Jayne GershkowitzSVP, Chief Patient Advocate5,693—5,693Jul 1, 2015 · 5:27 pm EDTForm 4
John KirkVP, Regulatory Affairs5,687—5,687May 12, 2015 · 9:43 pm EDTForm 4
Dipal DoshiSVP Strategy & Bus Dev1,706—1,706Jul 9, 2015 · 6:26 pm EDTForm 4
Julie YuVP Clinical Ops & Data Mgmt0—0Jun 16, 2015 · 8:14 pm EDTForm 4

Balances come from each insider’s most recent filing that reports a Table I holding; an insider who left the company years ago still appears with their last-known figure and its date. Indirect totals collapse multiple vehicles (trusts, LLCs) into one number — open the filing for the breakdown. Shares as filed, not split-adjusted.